Browse > Article

Study on the development of polycaprolacton silica nanohybrid for bone substitutes  

Jung, Keu-sik (Department of Periodontology, College of Dentistry, Dan-Kook University)
Lim, Sung-Bin (Department of Periodontology, College of Dentistry, Dan-Kook University)
Chung, Chin-Hyung (Department of Periodontology, College of Dentistry, Dan-Kook University)
Hong, Ki-Seok (Department of Periodontology, College of Dentistry, Dan-Kook University)
Kim, Jong-Yeo (Department of Oral Histology, College of Dentistry, Dan-Kook University)
Publication Information
Journal of Periodontal and Implant Science / v.34, no.2, 2004 , pp. 425-448 More about this Journal
Abstract
A bioactive and degradable poly(epsilon -caprolactone)/silica nanohybrid(PSH) was synthesized for the application as a bone substitute. PSH was manufactured by using silica and polycaprolacton. PSH was manufactured in some composition after low crystaline apatite had been formed in simulated body fluid and, was used this study. The safety of the PSH was established by test of acute, and subacute toxicity, sensitization cytotoxicity and sterility. In order to assess activity of osteoblast, the test for attaching osteoblast, proliferation test for osteoblast, differentiating gene expression test are performed in vitro. And bone substitutes were grafted in rabbit's calvarium, during 8 weeks for testing efficacy of bone substitutes. Degree of osteogenesis and absorption of substitutes were evaluated in microscopic level. In result, it was not appeared that acute and subacute toxicity, sensitization in intradermal induction phase, topical induction phase and challenge phase. It was shown that the test can not inhibit cell proliferation. adversely, it had some ability to accelerate cell proliferation. The result of sterility test described bacterial growth was not detected in most test tube. The attaching and proliferation test of osteoblast had good results. In the result of differentiating gene expression test for osteoblast, cbfa1 and, alkaline phosphatase, osteocalcin and GAPDH were detected with mRNA analysis. In the PSH bone formation test, ostgeoblastic activity would be different as material constitution but it had good new bone formation ability except group #218. futhermore, some material had been absorbed within 8 weeks. Above studies, PSH had bio-compatibility with human body, new bone formation ability and accelerate osteoblastic activity. So it would be the efficient bone substitute material with bio-active and biodegradable.
Keywords
polycaprolacton silica nanohybrid; bone substitute material; osteoblast;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bonassar LJ, Vacanti CA : Tissue engineering: the first decade and beyond. J Cell Biochem. Suppl 1998;30-31:297-303
2 Crane G, Ishuang S, Mikos A. : Bone Tissue Engineering: Nat Med. 1 : 1995;1322-1324
3 Cho SB. MivaJi F. Kokubo T. Nakamura T. : Induction of bioactivity of a non-bioactive glassceramic by a chemical treatment. Biomaterials. 1997;18(22):1479-1485
4 Dietmar Hutmacher, MS/Markus B. Hurzeler, Henning Schliephake : A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int J of Oral&Maxillofacial Implants. 1996;11:667-678
5 Greenstein G, Caton JG. : Biodegradable barriers and guided tissue regeneration. Periodontology 2000, 1993;1:36-45   DOI   ScienceOn
6 Chen J, Ma A, Lai Y, Chen Y, Cui M.: The mechanism of degradation for the absorbable biomaterials polyt(epsilon-caprolactone) in vitro and in vivo. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 1997;14(4):334-7   PUBMED
7 Goodwin CJ. Braden M. Downes S. Marshell NJ. : Release of bioactive human growth hormone from a biodegradable material: poly (epsilon -caprolactone),J Biomed Mater Res. 1998;40(2):204-13
8 Lang M. Bei J. Wang S. : Synthesis and characterization of polycaprolactone /poly( ethylene oxidel)/polylactide tri-componet copolymers.J Biomater Sci Polym Ed. 1999;10(4):501-12
9 Kweon H. Yoo MK. Park IK, Kim TH. Lee HC. Lee HS. Oh JS. Aka. : A novel degradable polycaprolactone networks for tissue engineering. Biomaterials. 2003;24(5):801-8
10 Li P. Ohtsuki C. Kokubo T, Nakanishi K, Saga N. Nakamura T. Yan : Effects of ions in aqueous media on hydroxyapatite induction by silica gel and its relevance to bioactivity of bioactive glasses and glass-ceramics. J Appl Biomater. 1993;4(3):221-9
11 Hollinger. J.O,, Battistone, G.C. : Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin, Orthop, 1986;207:290-305
12 Kazuo I and Toshie T : Enhancing effect of poly(L-lactide) on the differentiation of mouse osteoblast-like MC3T3-E1 cells Biomaterials. Aug;2003;24(19):3303-3309
13 우경미, Peter XM : 생체분해성 폴리머/칼슘포스 페이트결정 콤포지트 인공기질내로의 세포이주에 관한 연구 . 2000;대한구강해부학회지 27(1) :75-81
14 Schantz JT, Hutmacher DW, Ng KW, Khor HL, Lim MT, Teoh SH.: Evaluation of a tissue-engineered membrane-cell construct for guided bone regeneration.Int J Oral Maxillofac Implants. 2002;17(2):161-74   PUBMED
15 Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop 1981;157:259-278
16 Iooss P. Le Ray AM. Grimandi G. Daculsi G. Merle C. :A new injectable bone substitute combining poly(epsilon-caprolactone) microparticles with biphasic calcium phosphate granules. Biomaterials. 2001;22(20):2785-94
17 Gottlow J: Guided tissue regeneration using bioresorbable and non-resorbable devices ; Initial healing and long-term results. J Periodontol, 1993(supplement);64:1157-1167
18 Damien CJ, Parson JR, Bone graft and bone bone graft substitutes: A review of current technology and applications. J Appl Boimater 2: 1991;187-201
19 Elahiff CM. Blackwell AS. HOllisJM. Feldman DS. : Analysis of a biodegradable composite for bone healing. J Biomed Mater Res. 1996;32(3):419-24
20 Habal ME, Reddi AH: Different Forms of Bone Grafts. In Habal MB, Reddi AH(eds). Bone Graft and Bone Substitues. Philadelphia,WB Saunders 1992;6-8
21 Ahola M. Rich J. Kortesuo P, Kiesvaara J. Seppala J. Yli-Urpo A.: In vitro evaluation of biodegradable varepsilon-caprolactone-co-D, Llactide/ silica xerogel composites containing toremifene citrate. Int J Pharm. 1999;30;181(2):181-91
22 Radin S. Falaize S, Lee MH, Duchevne P. : In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. Biomaterials. 2002;23(15):3113-22
23 de Bruijn JD, van Bitterswijk CA, Davis JE. Initial bone matrix formation at the hydroxyapatite interface in nitro. J Biomed Mater Res 1995;29(1):89-99   DOI   ScienceOn
24 Rhee SH. Choi JY. Kim HM. : Preparation of a bioactive and degradable poly (epsilon - caprolactone)/silica hybrid through a sol-gel method. Biomaterials. 2002;Dec;23(24):4915-21
25 Rich J. Jaakkola T. Tirri T. Narhi T. Yli-Urpo A, Seppala J. : In vitro evaluation of poly(epsiloncaprolactone- co-DL-lactide)/ bioactive glass composites. Biomaterials, 2002;23(10):2143-50   DOI   ScienceOn
26 의료용구의 생물학적 안전에 관한 공통기준규격, 식품의약품안전청 고시 2000;제 2000-13호
27 Rhee SH : Effect of molecular weight of poly(varepsilon -caprolactone) on interpenetrating network structure, apatite-forming ability, and degradability of poly( varepsilon -caprolac-tone)/silica nano-hybrid materials. Biomaterials. 2003;24(10):1721-7   DOI   PUBMED   ScienceOn
28 Urist MR, O'Connor BT, Burwell RG: Bone Grafts Derivatives and Substitues. Oxford, Butterworth-Heinemann 1994
29 Okumura M. Ohgushi H. Dohi Y, Katuda T, Tarnai S, Koerten HK, Tabata S. Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res 1997;37:122-129
30 Oonishi H: Orthopaedic applications of hydroxyapatite. Biomaterials 12: 1991;171-178
31 Lin WJ. Flanagan DR, Linhardt RJ. : Accelerated degradation of poly (epsilon -eaprolactone) by organic amines.Pharm Res. 1994;11(7):1030-4
32 den Dunnen WF. Robinson PH. van Wessel R. Pennings AJ. van Lee : Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly (DL-lactide-epsiloncaprolactone), J Biomed Mater Res. 1997;5;36(3):337-46
33 Jarcho M. Retrospective analysis of hydroxyapatite development for oral implant applications. Dent Clin North Am 1992;36(1):19-26   PUBMED
34 Ignatius AA. Betz O. Augat P, Claes LE. : In vivo investigations on composites made of resorbable ceramics and poly(lactide) used as bone graft substitutes. J Biomed Mater Res. 2001;58(6):701-9
35 Ural E. Kesenci K. Fambri L. Migliaresi C. Piskin E. : Poly (D,L- lactide /epsilon -caprolactone) /hydroxyapatite composites. Biomaterials. 2000;21(21):2147-54